Shionogi
  • About
    • About Shionogi
      • Our leadership team
      • History and values
      • Global affiliates and locations
      • Investor relations
      • SBV EU Tax Initiatives
  • Sustainability
    • Sustainability
      • Tax strategy
      • Transparency
      • Governance, policies and position statements
      • Carbon reduction plan
  • Innovation
    • Innovation
      • Our areas of focus
      • Strategic partnering in Europe
      • Global innovation
      • Grants and donations
  • News
  • Investors
  • Careers
  • Contact
Europe
Worldwide
  1. Home
  2. News
  3. Press Releases
  4. Shionogi Launches Carbapenem-Type Antibiotic,"Finibax® 0.5g for Intravenous Drip Infusion"
Release
Medical News
2011/11/29

Shionogi Launches Carbapenem-Type Antibiotic,"Finibax® 0.5g for Intravenous Drip Infusion"

  • About
  • Sustainability
  • Innovation
  • Investors
  • News
  • Careers
  • Worldwide
  • Report Side Effect
  • Terms of Use
  • Cookie Policy
  • Contact Us
  • Sitemap
  • Privacy Policy
  • References
© Shionogi B.V. 2026. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Herengracht 464, 1017 CA, Amsterdam, the Netherlands.